We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Allient
ALNT
$1.92B
| $1.11M | ﹤0.01% |
31,878
-1,997
| -6% | -$65.8K |
|
|
TPC
2602
Tutor Perini Cor
TPC
$5.21B
| $1.11M | ﹤0.01% |
146,907
-22,888
| -13% | -$162K |
|
2603
Financial Institutions
FISI
$821M
| $1.1M | ﹤0.01% |
45,290
-7,691
| -15% | -$189K |
|
2604
Amplify Energy
AMPY
$166M
| $1.1M | ﹤0.01% |
125,380
-69,835
| -36% | -$594K |
|
2605
Esquire Financial Holdings
ESQ
$1.14B
| $1.1M | ﹤0.01% |
25,419
-4,217
| -14% | -$179K |
|
2606
Alerus Financial
ALRS
$828M
| $1.1M | ﹤0.01% |
47,050
-7,477
| -14% | -$170K |
|
2607
Bridgewater Bancshares
BWB
$603M
| $1.09M | ﹤0.01% |
61,683
-8,003
| -11% | -$147K |
|
2608
FuboTV Inc
FUBO
$273M
| $1.09M | ﹤0.01% |
52,099
-5,580
| -10% | -$204K |
|
|
JBIO
2609
Jade Biosciences
JBIO
$1.34B
| $1.09M | ﹤0.01% |
1,060
+61
| +6% | +$44.3K |
|
2610
uniQure
QURE
$3.22B
| $1.09M | ﹤0.01% |
47,901
+1,218
| +3% | +$26.3K |
|
2611
Southern Missouri Bancorp
SMBC
$850M
| $1.08M | ﹤0.01% |
23,660
-3,431
| -13% | -$173K |
|
2612
Cogent Biosciences
COGT
$7.24B
| $1.08M | ﹤0.01% |
218,184
-460,863
| -68% | -$5.71M |
|
2613
PetMed Express
PETS
$42.3M
| $1.08M | ﹤0.01% |
61,047
-4,034
| -6% | -$80.1K |
|
2614
Seer Inc
SEER
$120M
| $1.08M | ﹤0.01% |
186,298
-23,865
| -11% | -$161K |
|
2615
Saga Communications
SGA
$63.9M
| $1.08M | ﹤0.01% |
45,680
| – | – |
|
2616
iShares Core S&P 500 ETF
IVV
$902B
| $1.08M | ﹤0.01% |
2,800
-3,690
| -57% | -$1.42M |
|
2617
ACM Research
ACMR
$5.79B
| $1.07M | ﹤0.01% |
139,117
-25,312
| -15% | -$215K |
|
|
HTB
2618
HomeTrust Bancshares
HTB
$848M
| $1.06M | ﹤0.01% |
44,004
-10,002
| -19% | -$240K |
|
|
AMNB
2619
DELISTED
American National Bankshares Inc
AMNB
| $1.06M | ﹤0.01% |
28,750
-4,554
| -14% | -$166K |
|
2620
Mercantile Bank Corp
MBWM
$1.05B
| $1.06M | ﹤0.01% |
31,592
-12,613
| -29% | -$422K |
|
2621
OptimizeRx
OPRX
$133M
| $1.05M | ﹤0.01% |
62,770
+12,811
| +26% | +$222K |
|
2622
Full House Resorts
FLL
$89M
| $1.05M | ﹤0.01% |
140,157
-18,617
| -12% | -$129K |
|
|
CINC
2623
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $1.05M | ﹤0.01% |
85,520
-360
| -0.4% | -$8.58K |
|
2624
John Marshall Bancorp
JMSB
$329M
| $1.05M | ﹤0.01% |
36,377
-4,953
| -12% | -$138K |
|
2625
Build-A-Bear
BBW
$462M
| $1.04M | ﹤0.01% |
43,787
-6,048
| -12% | -$117K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.